|
nasdaq:incr
|
11776
|
May 5th, 2024 12:00AM
|
INC Research
|
95K
|
1226
|
Open
|
|
May 4th, 2024 11:40PM
|
May 4th, 2024 11:40PM
|
INC Research/inVentiv Health has become Syneos Health, the only fully integrated end-to-end clinical and commercial solution organization. We are purpose-built for biopharmaceutical acceleration, creating better, smarter, faster ways to help clients navigate an increasingly complex marketplace. Our new business addresses today’s market realities through clinical and commercial sharing expertise and data and insights to meet the needs of emerging and large global biopharmaceutical companies.
|
Open
|
CRO, CCO, and Biopharma
|
Open
|
3201 Beechleaf Court
|
Raleigh
|
North Carolina
|
US
|
27604
|
|
INC Research
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:incr
|
11776
|
May 4th, 2024 12:00AM
|
INC Research
|
95K
|
1226
|
Open
|
|
May 3rd, 2024 11:14PM
|
May 4th, 2024 06:54PM
|
INC Research/inVentiv Health has become Syneos Health, the only fully integrated end-to-end clinical and commercial solution organization. We are purpose-built for biopharmaceutical acceleration, creating better, smarter, faster ways to help clients navigate an increasingly complex marketplace. Our new business addresses today’s market realities through clinical and commercial sharing expertise and data and insights to meet the needs of emerging and large global biopharmaceutical companies.
|
Open
|
CRO, CCO, and Biopharma
|
Open
|
3201 Beechleaf Court
|
Raleigh
|
North Carolina
|
US
|
27604
|
|
INC Research
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:incr
|
11776
|
May 3rd, 2024 12:00AM
|
INC Research
|
95K
|
1226
|
Open
|
|
May 2nd, 2024 11:10PM
|
May 3rd, 2024 02:39PM
|
INC Research/inVentiv Health has become Syneos Health, the only fully integrated end-to-end clinical and commercial solution organization. We are purpose-built for biopharmaceutical acceleration, creating better, smarter, faster ways to help clients navigate an increasingly complex marketplace. Our new business addresses today’s market realities through clinical and commercial sharing expertise and data and insights to meet the needs of emerging and large global biopharmaceutical companies.
|
Open
|
CRO, CCO, and Biopharma
|
Open
|
3201 Beechleaf Court
|
Raleigh
|
North Carolina
|
US
|
27604
|
|
INC Research
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:incr
|
11776
|
May 2nd, 2024 12:00AM
|
INC Research
|
95K
|
1226
|
Open
|
|
May 1st, 2024 11:18PM
|
May 2nd, 2024 10:17AM
|
INC Research/inVentiv Health has become Syneos Health, the only fully integrated end-to-end clinical and commercial solution organization. We are purpose-built for biopharmaceutical acceleration, creating better, smarter, faster ways to help clients navigate an increasingly complex marketplace. Our new business addresses today’s market realities through clinical and commercial sharing expertise and data and insights to meet the needs of emerging and large global biopharmaceutical companies.
|
Open
|
CRO, CCO, and Biopharma
|
Open
|
3201 Beechleaf Court
|
Raleigh
|
North Carolina
|
US
|
27604
|
|
INC Research
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:incr
|
11776
|
May 1st, 2024 12:00AM
|
INC Research
|
95K
|
1226
|
Open
|
|
May 1st, 2024 12:22AM
|
May 1st, 2024 09:41AM
|
INC Research/inVentiv Health has become Syneos Health, the only fully integrated end-to-end clinical and commercial solution organization. We are purpose-built for biopharmaceutical acceleration, creating better, smarter, faster ways to help clients navigate an increasingly complex marketplace. Our new business addresses today’s market realities through clinical and commercial sharing expertise and data and insights to meet the needs of emerging and large global biopharmaceutical companies.
|
Open
|
CRO, CCO, and Biopharma
|
Open
|
3201 Beechleaf Court
|
Raleigh
|
North Carolina
|
US
|
27604
|
|
INC Research
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:incr
|
11776
|
Apr 30th, 2024 12:00AM
|
INC Research
|
95K
|
1226
|
Open
|
|
Apr 29th, 2024 11:37PM
|
Apr 30th, 2024 08:35AM
|
INC Research/inVentiv Health has become Syneos Health, the only fully integrated end-to-end clinical and commercial solution organization. We are purpose-built for biopharmaceutical acceleration, creating better, smarter, faster ways to help clients navigate an increasingly complex marketplace. Our new business addresses today’s market realities through clinical and commercial sharing expertise and data and insights to meet the needs of emerging and large global biopharmaceutical companies.
|
Open
|
CRO, CCO, and Biopharma
|
Open
|
3201 Beechleaf Court
|
Raleigh
|
North Carolina
|
US
|
27604
|
|
INC Research
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:incr
|
11776
|
Apr 29th, 2024 12:00AM
|
INC Research
|
95K
|
1226
|
Open
|
|
Apr 29th, 2024 12:00AM
|
Apr 29th, 2024 09:42AM
|
INC Research/inVentiv Health has become Syneos Health, the only fully integrated end-to-end clinical and commercial solution organization. We are purpose-built for biopharmaceutical acceleration, creating better, smarter, faster ways to help clients navigate an increasingly complex marketplace. Our new business addresses today’s market realities through clinical and commercial sharing expertise and data and insights to meet the needs of emerging and large global biopharmaceutical companies.
|
Open
|
CRO, CCO, and Biopharma
|
Open
|
3201 Beechleaf Court
|
Raleigh
|
North Carolina
|
US
|
27604
|
|
INC Research
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:incr
|
11776
|
Apr 28th, 2024 12:00AM
|
INC Research
|
95K
|
1227
|
Open
|
|
Apr 27th, 2024 11:31PM
|
Apr 27th, 2024 11:31PM
|
INC Research/inVentiv Health has become Syneos Health, the only fully integrated end-to-end clinical and commercial solution organization. We are purpose-built for biopharmaceutical acceleration, creating better, smarter, faster ways to help clients navigate an increasingly complex marketplace. Our new business addresses today’s market realities through clinical and commercial sharing expertise and data and insights to meet the needs of emerging and large global biopharmaceutical companies.
|
Open
|
CRO, CCO, and Biopharma
|
Open
|
3201 Beechleaf Court
|
Raleigh
|
North Carolina
|
US
|
27604
|
|
INC Research
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:incr
|
11776
|
Apr 27th, 2024 12:00AM
|
INC Research
|
95K
|
1227
|
Open
|
|
Apr 26th, 2024 11:11PM
|
Apr 26th, 2024 11:11PM
|
INC Research/inVentiv Health has become Syneos Health, the only fully integrated end-to-end clinical and commercial solution organization. We are purpose-built for biopharmaceutical acceleration, creating better, smarter, faster ways to help clients navigate an increasingly complex marketplace. Our new business addresses today’s market realities through clinical and commercial sharing expertise and data and insights to meet the needs of emerging and large global biopharmaceutical companies.
|
Open
|
CRO, CCO, and Biopharma
|
Open
|
3201 Beechleaf Court
|
Raleigh
|
North Carolina
|
US
|
27604
|
|
INC Research
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:incr
|
11776
|
Apr 26th, 2024 12:00AM
|
INC Research
|
95K
|
1228
|
Open
|
|
Apr 25th, 2024 11:18PM
|
Apr 26th, 2024 08:38AM
|
INC Research/inVentiv Health has become Syneos Health, the only fully integrated end-to-end clinical and commercial solution organization. We are purpose-built for biopharmaceutical acceleration, creating better, smarter, faster ways to help clients navigate an increasingly complex marketplace. Our new business addresses today’s market realities through clinical and commercial sharing expertise and data and insights to meet the needs of emerging and large global biopharmaceutical companies.
|
Open
|
CRO, CCO, and Biopharma
|
Open
|
3201 Beechleaf Court
|
Raleigh
|
North Carolina
|
US
|
27604
|
|
INC Research
|
Health Care
|
Pharmaceuticals & Biotechnology
|